User menu

Optimising TNM Staging of Patients with Prostate Cancer Using WB-MRI

Bibliographic reference Pasoglou, Vasiliki ; Michoux, Nicolas ; Tombal, Bertrand ; Lecouvet, Frédéric. Optimising TNM Staging of Patients with Prostate Cancer Using WB-MRI. In: Journal of the Belgian Society of Radiology, Vol. 100, no.1, p. 101 [1-11] (2016)
Permanent URL
  1. PC Foundation, Understanding Prostate Cancer (2015)
  2. Grönberg Henrik, Prostate cancer epidemiology, 10.1016/s0140-6736(03)12713-4
  3. Whittemore Alice S., Wu Anna H., Kolonel Laurence N., John Esther M., Gallagher Richard P., Howe Geoffrey R., West Dee W., Teh Chong-Ze, Stamey Thomas, Family History and Prostate Cancer Risk in Black, White, and Asian Men in the United States and Canada, 10.1093/oxfordjournals.aje.a117495
  4. Monroe Kristine R., Yu Mimi C., Kolonel Laurence N., Coetzee Gerhard A., Wilkens Lynne R., Ross Ronald K., Henderson Brian E., Evidence of an X-linked or recessive genetic component to prostate cancer risk, 10.1038/nm0895-827
  5. Thomson Vivien, Pialat Jean-Baptiste, Gay Frédéric, Coulon Agnès, Voloch Alain, Granier Anne, Guérin Jean-Claude, Viallon Magalie, Berthezene Yves, Whole-Body MRI for Metastases Screening: A Preliminary Study Using 3D VIBE Sequences With Automatic Subtraction Between Noncontrast and Contrast Enhanced Images : , 10.1097/coc.0b013e31815e3ff4
  6. Schröder Fritz H., Hugosson Jonas, Roobol Monique J., Tammela Teuvo L.J., Ciatto Stefano, Nelen Vera, Kwiatkowski Maciej, Lujan Marcos, Lilja Hans, Zappa Marco, Denis Louis J., Recker Franz, Berenguer Antonio, Määttänen Liisa, Bangma Chris H., Aus Gunnar, Villers Arnauld, Rebillard Xavier, van der Kwast Theodorus, Blijenberg Bert G., Moss Sue M., de Koning Harry J., Auvinen Anssi, Screening and Prostate-Cancer Mortality in a Randomized European Study, 10.1056/nejmoa0810084
  7. Bubendorf Lukas, Schöpfer Alain, Wagner Urs, Sauter Guido, Moch Holger, Willi Niels, Gasser Thomas C., Mihatsch Michael J., Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients, 10.1053/hp.2000.6698
  8. Engelbrecht Marc R., Jager Gerrit J., Laheij Robert J., Verbeek André L., van Lier H., Barentsz Jelle O., Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis, 10.1007/s00330-002-1389-z
  9. McLoud T C, Bourgouin P M, Greenberg R W, Kosiuk J P, Templeton P A, Shepard J A, Moore E H, Wain J C, Mathisen D J, Grillo H C, Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling., 10.1148/radiology.182.2.1732943
  10. Kayser K., Bach S., Bülzebruck H., Vogt-Moykopf I., Probst C., Site, size, and tumour involvement of resected extrapulmonary lymph nodes in lung cancer, 10.1002/jso.2930430112
  11. Gross B H, Glazer G M, Orringer M B, Spizarny D L, Flint A, Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance., 10.1148/radiology.166.1.3336704
  12. Hövels A.M., Heesakkers R.A.M., Adang E.M., Jager G.J., Strum S., Hoogeveen Y.L., Severens J.L., Barentsz J.O., The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis, 10.1016/j.crad.2007.05.022
  13. Schirrmeister Holger, Guhlmann Albrecht, Kotzerke Jörg, Santjohanser Claudia, Kühn Thorsten, Kreienberg Rolf, Messer Peter, Nüssle Karin, Elsner Klaus, Glatting Gerhard, Träger Harald, Neumaier Bernd, Diederichs Christoph, Reske Sven N., Early Detection and Accurate Description of Extent of Metastatic Bone Disease in Breast Cancer With Fluoride Ion and Positron Emission Tomography, 10.1200/jco.1999.17.8.2381
  14. Jacobson Arnold F., Fogelman Ignac, Bone scanning in clinical oncology: does it have a future?, 10.1007/s002590050287
  15. Lecouvet Frédéric E., El Mouedden Jawad, Collette Laurence, Coche Emmanuel, Danse Etienne, Jamar François, Machiels Jean-Pascal, Vande Berg Bruno, Omoumi Patrick, Tombal Bertrand, Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?, 10.1016/j.eururo.2012.02.020
  16. Lecouvet F. E., Simon M., Tombal B., Jamart J., Vande Berg B. C., Simoni P., Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa), 10.1007/s00330-010-1879-3
  17. Daffner RH, Lupetin AR, Dash N, Deeb ZL, Sefczek RJ, Schapiro RL, MRI in the detection of malignant infiltration of bone marrow, 10.2214/ajr.146.2.353
  18. Engelhard K., Hollenbach H. P., Wohlfart K., von Imhoff E., Fellner F. A., Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer, 10.1007/s00330-003-1968-7
  19. NAKANISHI Katsuyuki, KOBAYASHI Midori, TAKAHASHI Satoru, NAKATA Saki, KYAKUNO Miyaji, NAKAGUCHI Kazunori, NAKAMURA Hironobu, Whole Body MRI for Detecting Metastatic Bone Tumor: Comparison with Bone Scintigrams, 10.2463/mrms.4.11
  20. Gosfield, J Nucle Med, 34, 2191 (1993)
  21. Lecouvet Frédéric E., Vande Berg Bruno C., Malghem Jacques, Omoumi Patrick, Simoni Paolo, Diffusion-weighted MR Imaging: Adjunct or Alternative to T1-weighted MR Imaging for Prostate Carcinoma Bone Metastases?, 10.1148/radiol.2522090263
  22. Barkhausen Jörg, Quick Harald H., Lauenstein Thomas, Goyen Mathias, Ruehm Stefan G., Laub Gerhard, Debatin Jörg F., Ladd Mark E., Whole-Body MR Imaging in 30 Seconds with Real-Time True FISP and a Continuously Rolling Table Platform: Feasibility Study, 10.1148/radiology.220.1.r01jn07252
  23. Daldrup-Link Heike E., Franzius Christiane, Link Thomas M., Laukamp Daniela, Sciuk Joachim, Jürgens Heribert, Schober Otmar, Rummeny Ernst J., Whole-Body MR Imaging for Detection of Bone Metastases in Children and Young Adults : Comparison with Skeletal Scintigraphy and FDG PET, 10.2214/ajr.177.1.1770229
  24. Steinborn Marc M., Heuck Andreas F., Tiling Reinhold, Bruegel Melanie, Gauger Laurie, Reiser Maximilian F., Whole-Body Bone Marrow MRI in Patients with Metastatic Disease to the Skeletal System : , 10.1097/00004728-199901000-00026
  25. Flickinger Fred W., Sanal Salahattin M., Bone marrow MRI: Techniques and accuracy for detecting breast cancer metastases, 10.1016/0730-725x(94)92023-0
  26. Walker, J Magn Reson Imag, 343 (2000)
  27. Lecouvet Frédéric E., Whole-Body MR Imaging: Musculoskeletal Applications, 10.1148/radiol.2016142084
  28. Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka J T, Melhem E R, Yucel E K, A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases., 10.2214/ajr.169.6.9393186
  29. Berkovic Patrick, De Meerleer Gert, Delrue Louke, Lambert Bieke, Fonteyne Valérie, Lumen Nicolaas, Decaestecker Karel, Villeirs Geert, Vuye Philippe, Ost Piet, Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy, 10.1016/j.clgc.2012.08.003
  30. Jilg C.A., Rischke H.C., Reske S.N., Henne K., Grosu A.-L., Weber W., Drendel V., Schwardt M., Jandausch A., Schultze-Seemann W., Salvage Lymph Node Dissection with Adjuvant Radiotherapy for Nodal Recurrence of Prostate Cancer, 10.1016/j.juro.2012.08.041
  31. Larbi Ahmed, Dallaudière Benjamin, Pasoglou Vasiliki, Padhani Anwar, Michoux Nicolas, Vande Berg Bruno C., Tombal Bertrand, Lecouvet Frédéric E., Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease : WB-MRI Oligometastatic Prostate Cancer, 10.1002/pros.23196
  32. Heidenreich Axel, Identification of High-Risk Prostate Cancer: Role of Prostate-Specific Antigen, PSA Doubling Time, and PSA velocity, 10.1016/j.eururo.2008.06.077
  33. Heidenreich Axel, Bastian Patrick J., Bellmunt Joaquim, Bolla Michel, Joniau Steven, van der Kwast Theodor, Mason Malcolm, Matveev Vsevolod, Wiegel Thomas, Zattoni Filiberto, Mottet Nicolas, EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer, 10.1016/j.eururo.2013.11.002
  34. Heidenreich Axel, Bellmunt Joaquim, Bolla Michel, Joniau Steven, Mason Malcolm, Matveev Vsevolod, Mottet Nicolas, Schmid Hans-Peter, van der Kwast Theo, Wiegel Thomas, Zattoni Filliberto, EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease, 10.1016/j.eururo.2010.10.039
  35. Pasoglou Vasiliki, Larbi Ahmed, Collette Laurence, Annet Laurence, Jamar François, Machiels Jean-Pascal, Michoux Nicolas, Berg Bruno C. Vande, Tombal Bertrand, Lecouvet Frederic E., One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified “all-in-one” imaging approach? : One Step TNM Staging of Prostate Cancer Using MRI, 10.1002/pros.22764
  36. Shreve P D, Grossman H B, Gross M D, Wahl R L, Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose., 10.1148/radiology.199.3.8638000
  37. Ghosh Arundhati, Heston Warren D.W., Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer, 10.1002/jcb.10661
  38. Afshar-Oromieh A., Haberkorn U., Schlemmer H. P., Fenchel M., Eder M., Eisenhut M., Hadaschik B. A., Kopp-Schneider A., Röthke M., Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience, 10.1007/s00259-013-2660-z
  39. Afshar-Oromieh Ali, Zechmann Christian M., Malcher Anna, Eder Matthias, Eisenhut Michael, Linhart Heinz G., Holland-Letz Tim, Hadaschik Boris A., Giesel Frederik L., Debus Jürgen, Haberkorn Uwe, Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer, 10.1007/s00259-013-2525-5
  40. Afshar-Oromieh A., Malcher A., Eder M., Eisenhut M., Linhart H. G., Hadaschik B. A., Holland-Letz T., Giesel F. L., Kratochwil C., Haufe S., Haberkorn U., Zechmann C. M., PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions, 10.1007/s00259-012-2298-2
  41. Afshar-Oromieh Ali, Avtzi Eleni, Giesel Frederik L., Holland-Letz Tim, Linhart Heinz G., Eder Matthias, Eisenhut Michael, Boxler Silvan, Hadaschik Boris A., Kratochwil Clemens, Weichert Wilko, Kopka Klaus, Debus Jürgen, Haberkorn Uwe, The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer, 10.1007/s00259-014-2949-6
  42. Pasoglou Vasiliki, Michoux Nicolas, Tombal Bertrand, Jamar François, Lecouvet Frédéric E., wbMRI to detect bone metastases: critical review on diagnostic accuracy and comparison to other imaging modalities, 10.1007/s40336-015-0120-4
  43. Pasoglou Vasiliki, Michoux Nicolas, Peeters Frank, Larbi Ahmed, Tombal Bertrand, Selleslagh Tom, Omoumi Patrick, Vande Berg Bruno C., Lecouvet Frédéric E., Whole-Body 3D T1-weighted MR Imaging in Patients with Prostate Cancer: Feasibility and Evaluation in Screening for Metastatic Disease, 10.1148/radiol.14141242
  44. Nelson Joel B., Love William, Chin Joseph L., Saad Fred, Schulman Claude C., Sleep Darryl J., Qian Jiang, Steinberg Joyce, Carducci Michael, , Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer, 10.1002/cncr.23864
  45. Scher Howard I., Fizazi Karim, Saad Fred, Taplin Mary-Ellen, Sternberg Cora N., Miller Kurt, de Wit Ronald, Mulders Peter, Chi Kim N., Shore Neal D., Armstrong Andrew J., Flaig Thomas W., Fléchon Aude, Mainwaring Paul, Fleming Mark, Hainsworth John D., Hirmand Mohammad, Selby Bryan, Seely Lynn, de Bono Johann S., Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy, 10.1056/nejmoa1207506
  46. Hansen Jens, Auprich Marco, Ahyai Sascha A., de la Taille Alexandre, van Poppel Hendrik, Marberger Michael, Stenzl Arnulf, Mulders Peter F.A., Huland Hartwig, Fisch Margit, Abbou Clement-Claude, Schalken Jack A., Fradet Yves, Marks Leonard S., Ellis William, Partin Alan W., Pummer Karl, Graefen Markus, Haese Alexander, Walz Jochen, Briganti Alberto, Shariat Shahrokh F., Chun Felix K., Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 Assay, 10.1016/j.eururo.2012.07.030